David Schenkein

Insider Reports History

Entity
Individual
Location
C/O Bluebird Bio, Inc., 840 Memorial Drive, Cambridge, Massachusetts
Signature
/s/ William Cook, as Attorney-in-fact for David Schenkein
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Schenkein:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AGIOS PHARMACEUTICALS, INC. Director Common stock 126,242 $6.17 M $48.84 Jun 13, 2024 Direct
AGIOS PHARMACEUTICALS, INC. Director Common stock 79,082 $3.86 M $48.84 Jun 13, 2024 Indirect
Denali Therapeutics Inc. Director Common Stock 26,232 $535 K $20.39 May 31, 2024 Indirect
Denali Therapeutics Inc. Director Common Stock 21,496 $438 K $20.39 May 31, 2024 Direct
REGENERON PHARMACEUTICALS, INC. Director Common Stock 282 $268 K $951.26 Jan 2, 2024 Direct
AGIOS PHARMACEUTICALS, INC. Director Restricted stock units 2,120 $104 K $48.84 Jun 20, 2024 Direct
Prime Medicine, Inc. Director Stock Option (right to buy) 45,000 Jun 12, 2024 Direct
Denali Therapeutics Inc. Director Stock Option (right to buy) 17,901 May 31, 2024 Direct
AGIOS PHARMACEUTICALS, INC. Director Stock options (right to buy) 11,774 Jun 20, 2024 Direct
REGENERON PHARMACEUTICALS, INC. Director Non-Qualified Stock Option (right to buy) 508 Jan 2, 2024 Direct

Insider Reports Filed by David Schenkein

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AGIO AGIOS PHARMACEUTICALS, INC. Jun 20, 2024 2 0 4 Jun 24, 2024 Director
AGIO AGIOS PHARMACEUTICALS, INC. Jun 13, 2024 2 0 4 Jun 17, 2024 Director
PRME Prime Medicine, Inc. Jun 12, 2024 1 0 4 Jun 14, 2024 Director
DNLI Denali Therapeutics Inc. May 31, 2024 2 0 4 Jun 4, 2024 Director
AGIO AGIOS PHARMACEUTICALS, INC. Feb 27, 2024 6 -210,022 4 Feb 29, 2024 Director
AGIO AGIOS PHARMACEUTICALS, INC. Feb 23, 2024 6 -98,938 4 Feb 27, 2024 Director
REGN REGENERON PHARMACEUTICALS, INC. Jan 2, 2024 2 0 4 Jan 4, 2024 Director
REGN REGENERON PHARMACEUTICALS, INC. Sep 8, 2023 2 0 4 Sep 12, 2023 Director
REGN REGENERON PHARMACEUTICALS, INC. Sep 8, 2023 0 0 3 Sep 12, 2023 Director
AGIO AGIOS PHARMACEUTICALS, INC. Jun 21, 2023 2 0 4 Jun 23, 2023 Director
PRME Prime Medicine, Inc. Jun 14, 2023 1 0 4 Jun 16, 2023 Director
AGIO AGIOS PHARMACEUTICALS, INC. Jun 13, 2023 2 0 4 Jun 15, 2023 Director
DNLI Denali Therapeutics Inc. Jun 1, 2023 2 0 4 Jun 5, 2023 Director
AGIO AGIOS PHARMACEUTICALS, INC. Apr 3, 2023 3 -225,809 4 Apr 5, 2023 Director
AGIO AGIOS PHARMACEUTICALS, INC. Mar 27, 2023 3 -262,000 4 Mar 29, 2023 Director
AGIO AGIOS PHARMACEUTICALS, INC. Mar 13, 2023 4 -268,817 4 Mar 15, 2023 Director
AGIO AGIOS PHARMACEUTICALS, INC. Feb 27, 2023 3 -326,400 4 Mar 1, 2023 Director
AGIO AGIOS PHARMACEUTICALS, INC. Feb 13, 2023 3 -391,400 4 Feb 15, 2023 Director
AGIO AGIOS PHARMACEUTICALS, INC. Jan 30, 2023 4 -405,578 4 Feb 1, 2023 Director
AGIO AGIOS PHARMACEUTICALS, INC. Jan 17, 2023 4 -396,093 4 Jan 19, 2023 Director
PRME Prime Medicine, Inc. Oct 19, 2022 0 0 3 Oct 19, 2022 Director
AGIO AGIOS PHARMACEUTICALS, INC. Jun 21, 2022 2 0 4 Jun 23, 2022 Director
DNLI Denali Therapeutics Inc. Jun 2, 2022 2 0 4 Jun 6, 2022 Director
AGIO AGIOS PHARMACEUTICALS, INC. May 20, 2022 2 0 4 May 24, 2022 Director
AGIO AGIOS PHARMACEUTICALS, INC. Feb 22, 2022 3 -22,043 4 Feb 23, 2022 Director
DNLI Denali Therapeutics Inc. Jun 2, 2021 2 0 4 Jun 4, 2021 Director
DNLI Denali Therapeutics Inc. Jun 1, 2021 2 0 4 Jun 3, 2021 Director
AGIO AGIOS PHARMACEUTICALS, INC. May 28, 2021 2 0 4 Jun 2, 2021 Director
AGIO AGIOS PHARMACEUTICALS, INC. May 20, 2021 2 0 4 May 24, 2021 Director